Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Oncogene

• Publication date

  2014-08-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2014.244PMID 25088198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss

  2014cited by this paper
• p62/SQSTM1 is required for cell survival of apoptosis‐resistant bone metastatic prostate cancer cell lines

  2014cited by this paper
• β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.

  2013cited by this paper
• Autolysosomal β‐catenin degradation regulates Wnt‐autophagy‐p62 crosstalk

  2013cited by this paper
• Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells.

  2013cited by this paper
• The complex world of WNT receptor signalling

  2012cited by this paper
• Sequestosome 1/p62, a Scaffolding Protein, Is a Newly Identified Partner of IRS-1 Protein*

  2012cited by this paper
• p62/SQSTM1/A170: physiology and pathology.

  2012cited by this paper
• p62 is a key regulator of nutrient sensing in the mTORC1 pathway.

  2011cited by this paper
• Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells

  2011cited by this paper
• Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent

  2011cited by this paper
• Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling

  2011cited by this paper
• Subtle variations in Pten dose determine cancer susceptibility

  2010cited by this paper
• The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1

  2010cited by this paper
• p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription*

  2010cited by this paper
• The Double-Edged Sword of Autophagy Modulation in Cancer

  2009cited by this paper
• ErbB receptors and signaling pathways in cancer.

  2009cited by this paper
• Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling

  2009cited by this paper
• Autophagy suppresses tumorigenesis through elimination of p62.

  2009cited by this paper
• The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.

  2008cited by this paper
• A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression.

  2008cited by this paper
• Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.

  2007cited by this paper
• The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease.

  2007cited by this paper
• A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

  2007cited by this paper
• Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis.

  2007cited by this paper
• p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy*

  2007cited by this paper
• HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry

  2006cited by this paper
• Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2*

  2006cited by this paper
• p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

  2005cited by this paper
• p62 modulates Akt activity via association with PKCzeta in neuronal survival and differentiation.

  2005cited by this paper
• Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation

  2005cited by this paper
• Akt Stimulates Aerobic Glycolysis in Cancer Cells

  2004cited by this paper
• Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome Degradation

  2004cited by this paper
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

  2004cited by this paper
• Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.

  2004cited by this paper
• Down-regulation of the Tumor Suppressor PTEN by the Tumor Necrosis Factor-α/Nuclear Factor-κB (NF-κB)-inducing Kinase/NF-κB Pathway Is Linked to a Default IκB-α Autoregulatory Loop*

  2004cited by this paper
• p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• Reduced expression of PTEN correlates with breast cancer progression.

  2002cited by this paper
• Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies

  2001cited by this paper
• Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer

  2001cited by this paper
• Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

  1999cited by this paper
• NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

  1999cited by this paper
• Cancer cell lines

  1999cited by this paper
• Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.

  1998cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995cited by this paper
• The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.

  1992cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Induction of autophagy by amino-acid deprivation in perfused rat liver

  1977cited by this paper
• Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

  1975cited by this paper
• Regulation of Mammary Stem/progenitor Cells by Pten/ Akt/b-catenin Signaling

  year unknowncited by this paper

• Serum albumin exposure enhances cell invasiveness and paclitaxel resistance in human neuroblastoma cells, with attenuation by valeriana‐type iridoid glycosides

  2024cites this paper
• SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer

  2024cites this paper
• Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells.

  2024cites this paper
• Research Progress on the Expression of p62 in Colorectal Cancer and Its Clinical Application

  2024cites this paper
• CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis

  2023cites this paper
• High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer

  2022cites this paper
• Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

  2022cites this paper
• Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression.

  2021cites this paper
• Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)

  2021cites this paper
• Nanomaterial-mediated autophagy: coexisting hazard and health benefits in biomedicine

  2020cites this paper
• p62 as a therapeutic target for tumor.

  2020cites this paper
• Disruption of the EGFR-SQSTM1 Interaction by a Stapled Peptide Suppresses Lung Cancer via Activating Autophagy and Inhibiting EGFR Signaling.

  2020cites this paper
• The Potential Role of Nrf2-PD-L1 Axis in Promoting of Oxaliplatin Resistance in Colon Cancer Cells

  2020cites this paper
• Sequestosome 1 (p62) accumulation in breast cancer cells suppresses progesterone receptor expression via argonaute 2.

  2020cites this paper
• Prognostic Significance of LC3B and p62/SQSTM1 Expression in Gastric Adenocarcinoma

  2019cites this paper
• Potential Applications of NRF2 Inhibitors in Cancer Therapy

  2019cites this paper
• Isoaaptamine Induces T-47D Cells Apoptosis and Autophagy via Oxidative Stress

  2018cites this paper
• The Autophagy Receptor Adaptor p62 is Up‐regulated by UVA Radiation in Melanocytes and in Melanoma Cells

  2018cites this paper
• miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair

  2018cites this paper
• Autophagic Regulation of p62 is Critical for Cancer Therapy

  2018cites this paper
• The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.

  2018cites this paper
• New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity.

  2018cites this paper
• CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy

  2017cites this paper
• Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia

  2017cites this paper
• Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

  2017cites this paper
• VPS34 stimulation of p62 phosphorylation for cancer progression

  2017cites this paper
• Seeking new anti-cancer agents from autophagy-regulating natural products

  2017cites this paper
• Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors

  2017cites this paper
• p62 Regulates the Proliferation of Molecular Apocrine Breast Cancer Cells

  2016cites this paper
• p62/SQSTM1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer

  2016cites this paper
• Overexpression of cytoplasmic p 62 protein is associated with poor prognosis in gastric adenocarcinoma

  2016cites this paper
• High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.

  2015cites this paper
• Autophagy in malignant transformation and cancer progression

  2015cites this paper
• Oncosuppressive functions of decorin

  2015cites this paper
• p62: a hub of multiple signaling pathways in HER2-induced mammary tumorigenesis

  2015cites this paper
• ROLE OF BILE ACIDS AND FARNESOID X RECEPTOR IN HEPATIC AUTOPHAGY AND ITS IMPLICATIONS IN ETHANOL-INDUCED HEPATOTOXICITY

  2014cites this paper
• The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.

  2014cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper